COVID-19: Clinical Research

Return to Clinical Research

Read the following information from the Vice President for Research (VPR) regarding resuming clinical research.

 

Research ramp-up guidance:   https://research.virginia.edu/research-ramp-guidance

Human subject research specific guidance: https://research.virginia.edu/sites/vpr/files/2020-06/ReturnToClinicalResearchJune30.2020.pdf 

Collins Wing Clinical Research Unit

Operation status: Normal

Effective July 1, 2020: All clinical research studies can proceed on the Clinical Research Units only to the extent that it can be performed safely for research subjects and staff.

CRU Guidance for resuming operations_Collins

Fontaine Clinical Research Unit

Operation status: Normal

Effective July 1, 2020: All clinical research studies can proceed on the Clinical Research Units only to the extent that it can be performed safely for research subjects and staff.

CRU Guidance for resuming operations_Fontaine

Study monitoring visits

Updated March 4, 2021On site visits are still prohibited.

Until further notice, study monitors should not travel to UVA to conduct monitoring visits, site qualification visits, site initiation visits and/or site close-out visits.

There are four options for sharing information with study sponsors.  All four have been approved for use with patient (subject) related activities. For more information, click here.

Please note: Documentation of COVID-19 vaccination does not relax this restriction, all visits are prohibited.

Research Concierge at UVA Health Science Library

This service has been cancelled until further notice.

FAQ

There is a list of FAQs that you can reference to address your questions (https://research.virginia.edu/human-research-protection-program/COVID19FAQs).